MONNA 是一种有效的跨膜蛋白 16A (TMEM16A, Anoctamin-1) 阻断剂，IC50 为 80 nM。
| Cas No. | 1572936-83-4 |
| 别名 | 2-(4-甲氧基萘-2-基氨基)-5-硝基苯甲酸 |
| 化学名 | 2-[(4-methoxy-2-naphthalenyl)amino]-5-nitro-benzoic acid |
| Canonical SMILES | COC1=CC(NC2=C(C(O)=O)C=C([N+]([O-])=O)C=C2)=CC3=CC=CC=C31 |
| 分子式 | C18H14N2O5 |
| 分子量 | 338.3 |
| 溶解度 | DMF: 30 mg/ml,DMSO: 30 mg/ml,DMSO:PBS(pH 7.2) (1:3): 0.25 mg/ml,Ethanol: slightly soluble |
| 储存条件 | Store at -20°C |
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
| Shipping Condition | Evaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request |
| 产品描述 | MONNA is a selective inhibitor of anoctamin-1 (ANO1; IC50 = 0.08 uM in Xenopus oocytes), a calcium-activated chloride channel (CaCC). It is selective for ANO1 over the chloride channels bestrophin-1, chloride channel protein 2, and cystic fibrosis transmembrane conductance regulator up to 10 uM. MONNA (10 uM) induces full vasorelaxation of preconstricted mouse isolated mesenteric arteries in the presence or absence of chloride. It also hyperpolarizes isolated rat mesenteric arteries under resting conditions. |
m.cnreagent.com